Guardian Pharmacy Services Inc（GRDN）の財務GRDNGuardian Pharmacy Services Inc

Evaluating the bottom line, Guardian Pharmacy Services, Inc. maintains a gross margin of 22.75%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 5.87%, while the net margin is 6.29%. These profitability ratios, combined with a Return on Equity (ROE) of 31.75%, provide a clear picture of how effectively GRDN converts its operational activities into shareholder value.

In the context of the broader market, GRDN competes directly with industry leaders such as CVS. With a market capitalization of $2.67B, it holds a significant position in the sector. When comparing efficiency, GRDN's gross margin of 22.75% stands against CVS's 14.84%. Such benchmarking helps identify whether Guardian Pharmacy Services, Inc. is trading at a premium or discount relative to its financial performance.

Guardian has demonstrated solid financial performance, with total revenue increasing from $338.57 million in Q4 2024 to $397.62 million in Q4 2025. The net income has also shown improvement, rising from $11.94 million in Q4 2024 to $21.87 million in Q2 2026, reflecting a positive trend in profitability.